The role of cytokines in wound healing: from mechanistic insights to therapeutic applications

Abstract

Wound healing is an area of growing importance in the healthcare field, especially chronic wounds associated with comorbidities like diabetes mellitus (DM), hypoxic stress, obesity, and malnutrition. Chronic wounds significantly increase healthcare costs and reduce patients’ quality of life. Cytokines are a promising therapeutic target, as they regulate all stages of wound healing, and dysfunction in cytokine production can cause inflammatory non-healing wounds. Interleukin-1 (IL-1), IL-2, IL-6, IL-8, and tumour necrosis factor-α (TNF-α) facilitate leukocyte recruitment and clear dead cells during the initial inflammation stage while transforming growth factor-β (TGF-β), IL-4, and IL-13 inhibit inflammation and stimulate proliferation of fibroblasts to begin extracellular matrix (ECM) deposition. Given the complexity of cytokine interactions and their diverse cellular targets, a comprehensive understanding of these signaling pathways is crucial. This review examines the multifaceted roles of cytokines in wound healing and discusses recent advancements in the therapeutic application of cytokine modulation for improved wound care outcomes. Despite significant advancements in improving the specificity of cytokine therapies, further research is needed to focus on targeting downstream signaling pathways or specific receptors to minimize the adverse effects associated with these treatments.

Keywords

Wound healing / cytokines / wound regeneration / interleukins / growth factors

References

[1] Peña OA, Martin P. Cellular and molecular mechanisms of skin wound healing. Nat Rev Mol Cell Biol. 2024; 25: 599-616.

[2] Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014; 5: 491.

[3] Deckers J, Anbergen T, Hokke AM, de Dreu A, Schrijver DP, de Bruin K, et al. Engineering cytokine therapeutics. Nat Rev Bioeng. 2023; 1: 286-303.

[4] Elhabal SF, Abdelaal N, Saeed Al-Zuhairy SAK, Elrefai MFM, Elsaid Hamdan AM, Khalifa MM, et al. Green Synthesis of Zinc Oxide Nanoparticles from Althaea officinalis Flower Extract Coated with Chitosan for Potential Healing Effects on Diabetic Wounds by Inhibiting TNF-α and IL-6/IL-1β Signaling Pathways . Int J Nanomedicine. 2024; 19: 3045-70.

[5] 8 years ago, Singapore declared war on diabetes. Is it winning? [Internet]. National University of Singapore; [cited 2024 Nov 10]. Available from: https://sph.nus.edu.sg/blog/2024/10/31/8-years-ago-singapore-declared-war-on-diabetes-is-it-winning/

[6] Sen CK. Human Wound and Its Burden: Updated 2020 Compendium of Estimates. Adv Wound Care (New Rochelle). 2021; 10: 281-92.

[7] Sood A, Granick MS, Tomaselli NL. Wound Dressings and Comparative Effectiveness Data. Adv Wound Care (New Rochelle). 2014; 3: 511-29.

[8] James SMD, Sureshkumar S, Elamurugan TP, Debasis N, Vijayakumar C, Palanivel C. Comparison of Vacuum-Assisted Closure Therapy and Conventional Dressing on Wound Healing in Patients with Diabetic Foot Ulcer: A Randomized Controlled Trial. Niger J Surg. 2019; 25: 14-20.

[9] Agarwal P, Kukrele R, Sharma D. Vacuum assisted closure (VAC)/negative pressure wound therapy (NPWT) for difficult wounds: A review. J Clin Orthop Trauma. 2019; 10: 845-8.

[10] Teguh DN, Bol Raap R, Koole A, Knippenberg B, Smit C, Oomen J, et al. Hyperbaric oxygen therapy for nonhealing wounds: Treatment results of a single center. Wound Repair Regen. 2021; 29: 254-60.

[11] Yang TS, Nguyen LTH, Hsiao YC, Pan LC, Chang CJ. Biophotonic Effects of Low-Level Laser Therapy at Different Wavelengths for Potential Wound Healing. Photonics. 2022; 9: 591.

[12] Britto EJ, Nezwek TA, Popowicz P, Robins M. Wound Dressings. Treasure Island (FL): StatPearls Publishing; 2025.

[13] Su L, Jia Y, Fu L, Guo K, Xie S. The emerging progress on wound dressings and their application in clinic wound management. Heliyon. 2023; 9: e22520.

[14] Litwiniuk M, Krejner A, Speyrer MS, Gauto AR, Grzela T. Hyaluronic Acid in Inflammation and Tissue Regeneration. Wounds. 2016; 28: 78-88.

[15] Kim DS, Seong KY, Lee H, Kim MJ, An SM, Jeong JS, et al. Antiadhesive Hyaluronic Acid-Based Wound Dressings Promote Wound Healing by Preventing Re-Injury: An In Vivo Investigation. Biomedicines. 2024; 12: 510.

[16] Shu H, Xia Z, Qin X, Wang X, Lu W, Luo Q, et al. The clinical efficacy of collagen dressing on chronic wounds: A meta-analysis of 11 randomized controlled trials. Front Surg. 2022; 9: 978407.

[17] Olvera-Cortés V. Types of Skin Grafts. In: Gore M, editor. Skin Grafts for Successful Wound Closure. London: IntechOpen; 2021.

[18] Maskan Bermudez N, Sa BC, Hargis A, Yaghi M, Mervis J. Skin Grafting for Dermatologists: Past, Present, and Future. Curr Derm Rep. 2024; 13: 47-54.

[19] Farabi B, Roster K, Hirani R, Tepper K, Atak MF, Safai B. The Efficacy of Stem Cells in Wound Healing: A Systematic Review. Int J Mol Sci. 2024; 25: 3006.

[20] Raghuram AC, Yu RP, Lo AY, Sung CJ, Bircan M, Thompson HJ, et al. Role of stem cell therapies in treating chronic wounds: A systematic review. World J Stem Cells. 2020; 12: 659-75.

[21] Xu P, Wu Y, Zhou L, Yang Z, Zhang X, Hu X, et al. Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization. Burns Trauma. 2020; 8: tkaa028.

[22] Pretorius J, Habash M, Ghobrial B, Alnajjar R, Ellanti P. Current Status and Advancements in Platelet-Rich Plasma Therapy. Cureus. 2023; 15: e47176.

[23] Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020; 21: 7794.

[24] Kolimi P, Narala S, Nyavanandi D, Youssef AAA, Dudhipala N. Innovative Treatment Strategies to Accelerate Wound Healing: Trajectory and Recent Advancements. Cells. 2022; 11: 2439.

[25] Gharaee-Kermani M, Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des. 2001; 7: 1083-103.

[26] Chen Y, Zhang X, Liu Z, Yang J, Chen C, Wang J, et al. Obstruction of the formation of granulation tissue leads to delayed wound healing after scald burn injury in mice. Burns Trauma. 2021; 9: tkab004.

[27] Choudhary V, Choudhary M, Bollag WB. Exploring Skin Wound Healing Models and the Impact of Natural Lipids on the Healing Process. Int J Mol Sci. 2024; 25: 3790.

[28] Diller RB, Tabor AJ. The Role of the Extracellular Matrix (ECM) in Wound Healing: A Review. Biomimetics (Basel). 2022; 7: 87.

[29] Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb). 2012; 22: 49-62.

[30] Guo B, Dong R, Liang Y, Li M. Haemostatic materials for wound healing applications. Nat Rev Chem. 2021; 5: 773-91.

[31] Cioce A, Cavani A, Cattani C, Scopelliti F. Role of the Skin Immune System in Wound Healing. Cells. 2024; 13: 624.

[32] Jiang Y, Xu X, Xiao L, Wang L, Qiang S. The Role of microRNA in the Inflammatory Response of Wound Healing. Front Immunol. 2022; 13: 852419.

[33] Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004; 9: 283- 9.

[34] Rousselle P, Braye F, Dayan G. Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies. Adv Drug Deliv Rev. 2019; 146: 344-65.

[35] Shi Z, Yao C, Shui Y, Li S, Yan H. Research progress on the mechanism of angiogenesis in wound repair and regeneration. Front Physiol. 2023; 14: 1284981.

[36] Cialdai F, Risaliti C, Monici M. Role of fibroblasts in wound healing and tissue remodeling on Earth and in space. Front Bioeng Biotechnol. 2022; 10: 958381.

[37] Mahmoud NN, Hamad K, Al Shibitini A, Juma S, Sharifi S, Gould L, et al. Investigating Inflammatory Markers in Wound Healing: Understanding Implications and Identifying Artifacts. ACS Pharmacol Transl Sci. 2024; 7: 18-27.

[38] Gonzalez ACdO, Costa TF, Andrade ZdA, Medrado ARAP. Wound healing - A literature review. An Bras Dermatol. 2016; 91: 614-20.

[39] Darby IA, Laverdet B, Bonté F, Desmoulière A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014; 7: 301-11.

[40] Wallace HA, Basehore BM, Zito PM. Wound healing phases. Treasure Island (FL): StatPearls Publishing; 2025.

[41] Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006; 117: 35S-41S.

[42] Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005; 366: 1736-43.

[43] Ezhilarasu H, Vishalli D, Dheen ST, Bay BH, Srinivasan DK. Nanoparticle-Based Therapeutic Approach for Diabetic Wound Healing. Nanomaterials (Basel). 2020; 10: 1234.

[44] Yang X, Wang H, Song Z, Chen Q. Chronic Non-Healing Ulcers Associated with Atopic Inflammation: A Case Report. Clin Cosmet Investig Dermatol. 2022; 15: 1429-34.

[45] Hong WX, Hu MS, Esquivel M, Liang GY, Rennert RC, McArdle A, et al. The Role of Hypoxia-Inducible Factor in Wound Healing. Adv Wound Care (New Rochelle). 2014; 3: 390-9.

[46] Bai Q, Gao Q, Hu F, Zheng C, Sun N, Chen W, et al. Reoxygenation Modulates the Adverse Effects of Hypoxia on Wound Repair. Int J Mol Sci. 2022; 23: 15832.

[47] Cotterell A, Griffin M, Downer MA, Parker JB, Wan D, Longaker MT. Understanding wound healing in obesity. World J Exp Med. 2024; 14: 86898.

[48] Frasca D, Strbo N. Effects of Obesity on Infections with Emphasis on Skin Infections and Wound Healing. J Dermatol Skin Sci. 2022; 4: 5-10.

[49] Seth I, Lim B, Cevik J, Gracias D, Chua M, Kenney PS, et al. Impact of nutrition on skin wound healing and aesthetic outcomes: A comprehensive narrative review. JPRAS Open. 2024; 39: 291-302.

[50] González-Torres C, González-Martínez H, Miliar A, Nájera O, Graniel J, Firo V, et al. Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation. Nutrients. 2013; 5: 579-93.

[51] Bikker A, Wielders J, van Loo R, Loubert M. Ascorbic acid deficiency impairs wound healing in surgical patients: Four case reports. Int J Surg Open. 2016; 2: 15-8.

[52] Herberger K, Müller K, Protz K, Zyriax BC, Augustin M, Hagenström K. Nutritional status and quality of nutrition in chronic wound patients. Int Wound J. 2020; 17: 1246-54.

[53] Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci. 2021; 22: 2719.

[54] Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000; 50: 184-95.

[55] Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott M. Tumour necrosis factor signalling in health and disease. F1000Res. 2019; 8: F1000 Faculty Rev-111.

[56] Gough P, Myles IA. Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects. Front Immunol. 2020; 11: 585880.

[57] Medler J, Kucka K, Wajant H. Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy. Cancers (Basel). 2022; 14: 2603.

[58] Medler J, Wajant H. Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target. Expert Opin Ther Targets. 2019; 23: 295-307.

[59] Denadai R, Teixeira FV, Steinwurz F, Romiti R, Saad-Hossne R. Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases. J Crohns Colitis. 2013; 7: 517-24.

[60] Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum. 2010; 40: 233- 40.

[61] Wendling D, Prati C. Paradoxical effects of anti-TNF-α agents in inflammatory diseases. Expert Rev Clin Immunol. 2014; 10: 159-69.

[62] Vunnam N, Yang M, Lo CH, Paulson C, Fiers WD, Huber E, et al. Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. ACS Bio Med Chem Au. 2023; 3: 270-82.

[63] Sedger LM, McDermott MF. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014; 25: 453-72.

[64] Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of Acute and Chronic Wound Healing. Biomolecules. 2021; 11: 700.

[65] Shanley LC, Mahon OR, Kelly DJ, Dunne A. Harnessing the innate and adaptive immune system for tissue repair and regeneration: Considering more than macrophages. Acta Biomater. 2021; 133: 208-21.

[66] Freitas MO, Fonseca APR, de Aguiar MT, Dias CC, Avelar RL, Sousa FB, et al. Tumor necrosis factor alpha (TNF-α) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats. Inflammopharmacology. 2022; 30: 1781-98.

[67] Ueda A, Takeno M, Ishigatsubo Y. Adalimumab in the management of Behçet’s disease. Ther Clin Risk Manag. 2015; 11: 611-9.

[68] Yu J, Shin SJ, Park YJ, Kim HW, Lee BI, Ye BD, et al. Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea. BMC Gastroenterol. 2023; 23: 449.

[69] Xiaojie W, Banda J, Qi H, Chang AK, Bwalya C, Chao L, et al. Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-2. Cytokine Growth Factor Rev. 2022; 66: 26-37.

[70] Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-β signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024; 9: 61.

[71] Batlle E, Massagué J. Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity. 2019; 50: 924-40.

[72] Tzavlaki K, Moustakas A. TGF-β Signaling. Biomolecules. 2020; 10: 487.

[73] Ogata FT, Verma S, Coulson-Thomas VJ, Gesteira TF. TGF-β-Based Therapies for Treating Ocular Surface Disorders. Cells. 2024; 13: 1105.

[74] Devan AR, Pavithran K, Nair B, Murali M, Nath LR. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World J Gastroenterol. 2022; 28: 5250-64.

[75] Ong CH, Tham CL, Harith HH, Firdaus N, Israf DA. TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies. Eur J Pharmacol. 2021; 911: 174510.

[76] Sanjabi S, Oh SA, Li MO. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. Cold Spring Harb Perspect Biol. 2017; 9: a022236.

[77] Massagué J, Sheppard D. TGF-β signaling in health and disease. Cell. 2023; 186: 4007-37.

[78] Liarte S, Bernabé-García Á, Nicolás FJ. Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective. Cells. 2020; 9: 306.

[79] van den Bulk J, de Miranda NFCC, Ten Dijke P. Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression. Clin Sci (Lond). 2021; 135: 35-52.

[80] Urban L, Čoma M, Lacina L, Szabo P, Sabová J, Urban T, et al. Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis. Histochem Cell Biol. 2023; 160: 541-54.

[81] Xu X, Khoong YM, Gu S, Huang X, Ren JY, Gu YH, et al. Investigating the potential of LSKL peptide as a novel hypertrophic scar treatment. Biomed Pharmacother. 2020; 124: 109824.

[82] McCollum PT, Bush JA, James G, Mason T, O’Kane S, McCollum C, et al. Randomized phase II clinical trial of avotermin versus placebo for scar improvement. Br J Surg. 2011; 98: 925-34.

[83] Puolakkainen PA, Reed MJ, Gombotz WR, Twardzik DR, Abrass IB, Sage HE. Acceleration of wound healing in aged rats by topical application of transforming growth factor-β₁ . Wound Repair Regen. 1995; 3: 330-9.

[84] Robson MC, Phillip LG, Cooper DM, Lyle WG, Robson LE, Odom L, et al. Safety and effect of transforming growth factor-β₂ for treatment of venous stasis ulcers . Wound Repair Regen. 1995; 3: 157-67.

[85] Johnson KE, Wilgus TA. Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. Adv Wound Care (New Rochelle). 2014; 3: 647-61.

[86] Huang YH, Yang HY, Huang SW, Ou G, Hsu YF, Hsu MJ. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. PLoS One. 2016; 11: e0158839.

[87] Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996; 380: 435-9.

[88] Bang FS, Leeberg V, Ding M, Dreyer CH. The effect of VEGF stimulation in diabetic foot ulcers: A systematic review. Wound Repair Regen. 2024; 32: 384-92.

[89] Tazawa K, Azuma Presse MM, Furusho H, Stashenko P, Sasaki H. Revisiting the role of IL-1 signaling in the development of apical periodontitis. Front Dent Med. 2022; 3: 985558.

[90] Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018; 281: 8-27.

[91] Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011; 117: 3720-32.

[92] Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest. 2007; 117: 3786-99.

[93] Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3: cm1.

[94] Tahtinen S, Tong A, Himmels P, Oh J, Paler-Martinez A, Kim L, et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 2022; 23: 532-42.

[95] Perrault DP, Bramos A, Xu X, Shi S, Wong AK. Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing. Ann Plast Surg. 2018; 80: S317-21.

[96] Tan JL, Lash B, Karami R, Nayer B, Lu Y, Piotto C, et al. Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist. Commun Biol. 2021; 4: 422.

[97] Shen S, Miskolci V, Dewey CN, Sauer JD, Huttenlocher A. Infection induced inflammation impairs wound healing through IL-1β signaling. iScience. 2024; 27: 109532.

[98] Dai J, Shen J, Chai Y, Chen H. IL-1 β Impaired Diabetic Wound Healing by Regulating MMP-2 and MMP-9 through the p38 Pathway . Mediators Inflamm. 2021; 2021: 6645766.

[99] Ross SH, Cantrell DA. Signaling and Function of Interleukin-2 in T Lymphocytes. Annu Rev Immunol. 2018; 36: 411-33.

[100] Hirakawa M, Matos TR, Liu H, Koreth J, Kim HT, Paul NE, et al. Low-dose IL-2 selectively activates subsets of CD4⁺ Tregs and NK cells . JCI Insight. 2016; 1: e89278.

[101] Passerini L, Allan SE, Battaglia M, Nunzio SD, Alstad AN, Levings MK, et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4⁺CD25⁺ regulatory T cells and CD4⁺CD25^- effector T cells . Int Immunol. 2008; 20: 421-31.

[102] Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006; 117: 12S-34S.

[103] Doersch KM, DelloStritto DJ, Newell-Rogers MK. The contribution of interleukin-2 to effective wound healing. Exp Biol Med (Maywood). 2017; 242: 384-96.

[104] Cozzolino F, Torcia M, Lucibello M, Morbidelli L, Ziche M, Platt J, et al. Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest. 1993; 91: 2504-12.

[105] Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG. Burns: Pathophysiology of Systemic Complications and Current Management. J Burn Care Res. 2017; 38: e469-81.

[106] Raeber ME, Sahin D, Karakus U, Boyman O. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases. EBioMedicine. 2023; 90: 104539.

[107] Gadani SP, Cronk JC, Norris GT, Kipnis J. IL-4 in the brain: a cytokine to remember. J Immunol. 2012; 189: 4213-9.

[108] Walker JA, McKenzie ANJ. T_H2 cell development and function . Nat Rev Immunol. 2018; 18: 121-33.

[109] Keegan AD, Leonard WJ, Zhu J. Recent advances in understanding the role of IL-4 signaling. Fac Rev. 2021; 10: 71.

[110] Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17: 701-38.

[111] Junttila IS. Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes. Front Immunol. 2018; 9: 888.

[112] Allen JE. IL-4 and IL-13: Regulators and Effectors of Wound Repair. Annu Rev Immunol. 2023; 41: 229-54.

[113] Martí I Líndez AA, Reith W. Arginine-dependent immune responses. Cell Mol Life Sci. 2021; 78: 5303-24.

[114] Kim SY, Nair MG. Macrophages in wound healing: activation and plasticity. Immunol Cell Biol. 2019; 97: 258-67.

[115] Szondi DC, Wong JK, Vardy LA, Cruickshank SM. Arginase Signalling as a Key Player in Chronic Wound Pathophysiology and Healing. Front Mol Biosci. 2021; 8: 773866.

[116] Lauterbach AL, Wallace RP, Alpar AT, Refvik KC, Reda JW, Ishihara A, et al. Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds. NPJ Regen Med. 2023; 8: 49.

[117] Nguyen JK, Austin E, Huang A, Mamalis A, Jagdeo J. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Arch Dermatol Res. 2020; 312: 81-92.

[118] Metko D, Alkofide M, Abu-Hilal M. A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities. JAAD Int. 2024; 15: 5-11.

[119] Min MS, Mazori DR, Lee MS, Merola JF, Vleugels RA, Cobos G, et al. Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab. J Drugs Dermatol. 2023; 22: 1220-2.

[120] Benakanakere MR, Finoti LS, Tanaka U, Grant GR, Scarel-Caminaga RM, Kinane DF. Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editing. Sci Rep. 2016; 6: 31180.

[121] Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L1094-103.

[122] Korbecki J, Kupnicka P, Chlubek M, Gorący J, Gutowska I, Baranowska-Bosiacka I. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. Int J Mol Sci. 2022; 23: 2168.

[123] Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun. 1999; 67: 1471-80.

[124] Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: An evolving chemokine. Cytokine. 2022; 153: 155828.

[125] Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994; 56: 559-64.

[126] Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, et al. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol. 2022; 12: 808797.

[127] Alraouji NN, Aboussekhra A. Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells. Mol Carcinog. 2021; 60: 51-9.

[128] Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011; 6: e21381.

[129] Jiang WG, Sanders AJ, Ruge F, Harding KG. Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications. Exp Ther Med. 2012; 3: 231-6.

[130] Matsui C, Koide H, Ikeda T, Ikegami T, Yamamoto T, Escandón JM, et al. Cytokines released from human adipose tissue-derived stem cells by bFGF stimulation: Effects of IL-8 and CXCL-1 on wound healing. Regen Ther. 2024; 26: 401-6.

[131] Zhang Y, Jiang W, Kong L, Fu J, Zhang Q, Liu H. PLGA@IL-8 nanoparticles-loaded acellular dermal matrix as a delivery system for exogenous MSCs in diabetic wound healing. Int J Biol Macromol. 2023; 224: 688-98.